
Recombinant humaan Kallikreïne 5/KLK5 (C-6His)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
Source: Human Cells. MW :30.65kD. Recombinant Human Kallikrein 5 is produced by our Mammalian expression system and the target gene encoding Val23-Ser293 is expressed with a 6His tag at the C-terminus. Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many Kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen Kallikrein subfamily members located in a cluster on chromosome 19. Its encoded protein is secreted and may play a role in suppression of tumorigenesis in breast and prostate cancers. Alternate splicing of this gene results in multiple transcript variants encoding the same protein.
KLK5
25818
Q9Y337
Supplied as a 0.2 μm filtered solution of 20mM MES, 150mM NaCl, 10% Glycerol, pH 5.5.
The product is shipped on dry ice/ice packs.
Store at -20°C, stable for 6 months after receipt. Please minimize freeze-thaw cycles.
Endotoxin : Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test.
VTEHVLANNDVSCDHPSNTVPSGSNQDLGAGAGEDARSDDSSSRIINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKKVFRVRLGHYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVSSHCPSAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYPRQIDDTMFCAGDKAGRDSCQGDSGGPVVCNGSLQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQETIQANSVDHHHHHH
Beschrijving
Source: Human Cells. MW :30.65kD. Recombinant Human Kallikrein 5 is produced by our Mammalian expression system and the target gene encoding Val23-Ser293 is exp
Specificaties
Recent bekeken producten

0.22μm Syringe Filter
F1021
13mm, 50 / Pk, 500 / Cs

Erdafitinib
B2458-25
25 mg

TRPM4-IN-2
BA7024-1
1 mg

TRPM4-IN-1
HY-122605-01
5 mg

Anti-RAVV Envelope glycoprotein/GP Recombinant Antibody (SAA2752)
VK160013-01
50 µg

Recombinant BoHV-1 Envelope glycoprotein E
DRA167-01
50 µg

GelRed® Agarose LE
#41029-5G
1x 5 g

50 ml Disposable Serological Pipette
CPP00050
100/CS

